Navigation Links
AllCells Introduces Autoimmune Diseased Cells and Tissue Products
Date:9/11/2012

EMERYVILLE, Calif., Sept. 11, 2012 /PRNewswire/ -- AllCells, LLC, a leading provider of healthy & diseased hematopoietic tissues, primary cell types, and related services to the global life science industry has announced the release of new autoimmune diseased cells and tissue products. The specimens may be used in preclinical research, drug discovery, drug toxicity, diagnostic related assays, and other life science research applications. All products are indicated for in vitro research use only.

"The introduction of this autoimmune product line fulfills a vital need by our customers to obtain hematologic samples from a variety of autoimmune indications. These products serve as essential components of cell-based assays commonly used in the work-flow of our customers' preclinical research projects," commented Eric Martinelli, Business Development Manager.  

AllCells provides peripheral blood and/or isolated cell types from patients diagnosed with Autoimmune diseases such as  Rheumatoid Arthritis, Osteoarthritis, Systemic Lupus Erythematosus (SLE), Psoriasis, Type I & Type II Diabetes, and Multiple Sclerosis. Autoimmune plasma and peripheral blood mononuclear cells are available from each disease type.

Patient treatment history and clinical reports are available for each sample, and may include auto antibody analysis and/or clinical diagnostic scores (ACR, SLEDAI, etc.). Autoimmune Diseased Cells & Tissue products are obtained from volunteers participating in an Institutional Review Board (IRB) or Human Subject Committee approved donor program. All donors sign an informed consent form, and are screened for infectious diseases (HIV, Hepatitis B & C).

For more information about autoimmune diseased cells and tissue specimens, visit www.AllCells.com.

Full release available here:  http://www.allcells.com/blog/allcells-introduces-autoimmune-diseased-cells-and-tissue-products/.    

About AllCells, LLC
AllCells, LLC is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.


'/>"/>
SOURCE AllCells, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. AllCells, LLC Named to Inc. Magazines 500/5000 List of Fastest Growing Companies
2. Vision Research Introduces the Newest Member Of the Phantom®- 1Mpx- v-Series Camera Family
3. JPSA Introduces Picosecond Laser Micromachining System
4. Profit Lifter for Pro Mold Removers: Molderizer Introduces Remediation Product Like No Other
5. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
6. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
7. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
8. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
9. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
10. Genalyte Launches Maverick ENA Kits For Fast, Easy And Accurate Multiplexed Autoimmune Testing
11. Stem Cells Bring New Hope for Parry-Romberg Syndrome Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... RURO, Inc., ... version of LimitLIS®, its rapidly growing Laboratory Information System. , LimitLIS® version 3 ... installation integrity, and provide more customization options. Each of these has been “under ...
(Date:6/22/2017)... , ... June 21, 2017 , ... ... and hiring top executive talent in the life sciences industry, today announces a ... company. The partnership takes full advantage of Beaker’s expertise in executive recruitment ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... leaders in designating infertility as a disease, bringing new hope for prospective parents ... their 2017 annual meeting to back the World Health Organization’s designation in hopes ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... release of Limfinity® version 6.5, a content-packed update to the Limfinity® framework. , ... a larger and more diverse base of customers among labs and other businesses. ...
Breaking Biology Technology:
(Date:3/22/2017)... , March 21, 2017 Optimove ... used by retailers such as 1-800-Flowers and AdoreMe, ... — Product Recommendations and Replenishment. Using Optimove,s machine learning ... personalized product and replenishment recommendations to their customers ... on predictions of customer intent drawn from a ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited the ... the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... largest German biometrics company the two government leaders could see the three ... as DERMALOG´s multi-biometrics system.   Continue Reading ... ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. ... Used combined in one project, multi-biometric solutions ... ...
Breaking Biology News(10 mins):